ARWR- Arrowhead Pharmaceuticals, Inc.

Name: Arrowhead Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Anzalone Christopher Richard	3.79M	$311.00M	-
COO	O'Brien Patrick	473.3K	$38.81M	-
Other	Hamilton James C	227.0K	$18.61M	-
CFO	Apel Daniel Joseph	162.9K	$13.36M	-
Dir	Perry Michael S	123.1K	$10.09M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 15, 2021	Anzalone Christopher Richard60	Chief Executive Officer	Sell	60,000	$67.56	$4,053,431.46	-0.4%	-42.1%	-55.3%
Nov 19, 2021	San Martin Javier65	Chief Medical Officer	Sell	19,500	$69.31	$1,351,589.00	-5.4%	-36.5%	-56.8%
Oct 22, 2021	Anzalone Christopher Richard60	Chief Executive Officer	Sell	65,000	$65.77	$4,274,981.60	-0.7%	-20.5%	-49.4%
Sep 13, 2021	Olukotun Adeoye Y52	Director	Sell	5,000	$63.76	$318,800.00	-19.4%	+11.0%	-44.3%
Sep 9, 2021	Given Douglas B66	Director	Sell	5,000	$65.24	$326,200.00	-4.4%	+13.3%	-40.9%
Jun 24, 2021	De Backer Marianne65	Director	Sell	5,000	$89.85	$449,250.00	-18.9%	-29.9%	-61.5%
Jun 22, 2021	Hassard James61	Chief Commercial Officer	Sell	3,625	$89.22	$323,422.50	-3.3%	-29.8%	-64.5%
Jun 22, 2021	Given Douglas B66	Director	Sell	4,500	$89.21	$401,445.00	-3.8%	-29.8%	-64.5%
Feb 22, 2021	Given Douglas B66	Director	Sell	1,125	$88.73	$99,821.25	-7.5%	-12.0%	-49.3%
Feb 8, 2021	O'Brien Patrick76	General Counsel	Sale+OE	90,000	$88.46	$7,961,240.32	-6.4%	-25.2%	-41.0%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC